At birth, Miles was diagnosed with severe Hemophilia A, a rare bleeding disorder that requires him to intravenously inject himself with medication every day. Needlestick injuries cost the United States healthcare sector over $3 billion a year and 25% of venipuncture procedures performed by trained nurses are unsuccessful on the first attempt. This is what inspired Miles to start Invictis Technologies with Princeton MAE professor Craig Arnold, building a small cuff-like robotic device called VITA that automatically performs an IV injection with extreme accuracy - removing the human error from this outdated and dangerous process. Similar to how the EpiPen changed the landscape for epinephrine delivery, VITA will be adopted as the new standard method for safely and easily delivering IV injections.
Miles Cole, '21
Founder, Invictis Technologies